Sintx Technologies Past Earnings Performance

Past criteria checks 0/6

Sintx Technologies has been growing earnings at an average annual rate of 1.2%, while the Medical Equipment industry saw earnings growing at 1.9% annually. Revenues have been growing at an average rate of 40.7% per year.

Key information

1.2%

Earnings growth rate

97.3%

EPS growth rate

Medical Equipment Industry Growth-9.5%
Revenue growth rate40.7%
Return on equity-208.7%
Net Margin-358.8%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Sintx Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

LSE:0A8S Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 243-1256
30 Jun 243-958
31 Mar 243-959
31 Dec 233-859
30 Sep 232-1469
30 Jun 232-1468
31 Mar 232-1467
31 Dec 222-1656
30 Sep 221-1056
30 Jun 221-1056
31 Mar 221-1056
31 Dec 211-956
30 Sep 211-956
30 Jun 210-946
31 Mar 210-1145
31 Dec 201-1745
30 Sep 201-1644
30 Jun 201-1534
31 Mar 201-1434
31 Dec 191-733
30 Sep 191-843
30 Jun 190-1533
31 Mar 190-2243
31 Dec 180-2443
30 Sep 180-2443
30 Jun 18-6-1713
31 Mar 18-3-933
31 Dec 170-644
30 Sep 174-574
30 Jun 1713-15136
31 Mar 1714-18156
31 Dec 1615-21166
30 Sep 1617-22176
30 Jun 1618-21176
31 Mar 1619-22186
31 Dec 1519-24196
30 Sep 1520-31196
30 Jun 1521-26237
31 Mar 1522-33308
31 Dec 1423-33327
30 Sep 1423-22336
30 Jun 1423-20305
31 Mar 1423-9253
31 Dec 1322-8223

Quality Earnings: 0A8S is currently unprofitable.

Growing Profit Margin: 0A8S is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 0A8S is unprofitable, but has reduced losses over the past 5 years at a rate of 1.2% per year.

Accelerating Growth: Unable to compare 0A8S's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 0A8S is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (39.9%).


Return on Equity

High ROE: 0A8S has a negative Return on Equity (-208.74%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 12:22
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sintx Technologies, Inc. is covered by 6 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Edward WooAscendiant Capital Markets LLC
David TurkalyJMP Securities
Jeffrey CohenLadenburg Thalmann & Company